Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-07 Purchase |
2023-11-09 8:36 pm |
Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner |
454,545 | $11 | $4,999,995 | 2,157,623 (Direct) |
View |
| 2023-11-07 Purchase |
2023-11-09 8:33 pm |
Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner |
227,272 | $11 | $2,499,992 | 1,835,959 (Direct) |
View |
| 2023-11-07 Purchase |
2023-11-09 8:32 pm |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
454,545 | $11 | $4,999,995 | 2,567,100 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-05 Option Award |
2024-01-09 6:50 pm |
N/A 2034-01-04 |
Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal and Admin Officer |
166,250 | $0 | 166,250 (Direct) |
View |
| 2023-11-07 Conversion |
2023-11-09 8:36 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner |
19,318,610 | $0 | 2,157,623 (Direct) |
View |
| 2023-11-07 Conversion |
2023-11-09 8:35 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | McCormac Paul Chief Technical Officer |
32,252 | $0 | 17,349 (Direct) |
View |
| 2023-11-07 Conversion |
2023-11-09 8:33 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner |
18,224,219 | $0 | 1,835,959 (Direct) |
View |
| 2023-11-07 Conversion |
2023-11-09 8:32 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
24,018,702 | $0 | 2,567,100 (Indirect) |
View |
Ownership |
2023-11-02 9:42 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Townsend Richard Nolan Chief Executive Officer |
0 | $0 | 906,222 (Direct) |
View |
Ownership |
2023-11-02 9:41 pm |
N/A 2032-05-05 |
Lexeo Therapeutics Inc. | LXEO | Robertson Jenny Chief Legal and Admin. Officer |
0 | $0 | 135,516 (Direct) |
View |
Ownership |
2023-11-02 9:40 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Omega Fund VI L.P. Omega Fund VI GP L.P. Omega Fund VI GP Manager Ltd. Stampacchia Otello Nessi Claudio Paster Anne-Mari 10% Owner |
0 | $0 | 1,662,748 (Direct) |
View |
Ownership |
2023-11-02 9:38 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | McCormac Paul Chief Technical Officer |
0 | $0 | 184,368 (Direct) |
View |
Ownership |
2023-11-02 9:37 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Lundbeckfond Invest A/S 10% Owner |
0 | $0 | 1,568,357 (Direct) |
View |
Ownership |
2023-11-02 9:36 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
0 | $0 | 2,067,743 (Indirect) |
View |
Ownership |
2023-11-02 9:19 pm |
N/A 2033-08-21 |
Lexeo Therapeutics Inc. | LXEO | COOPERSTONE BRENDA Director |
0 | $0 | 59,812 (Direct) |
View |
Ownership |
2023-11-02 9:17 pm |
N/A N/A |
Lexeo Therapeutics Inc. | LXEO | CHOLMONDELEY PAULA H Director |
0 | $0 | 59,811 (Direct) |
View |
Ownership |
2023-11-02 9:16 pm |
N/A 2031-02-15 |
Lexeo Therapeutics Inc. | LXEO | Altschuler Steven Director |
0 | $0 | 119,625 (Direct) |
View |
Ownership |
2023-11-02 9:14 pm |
N/A 2031-11-03 |
Lexeo Therapeutics Inc. | LXEO | Adler Eric Chief Scientific Officer |
0 | $0 | 256,679 (Direct) |
View |